Case Report and Genomic Analysis of Cefiderocol-Resistant Escherichia coli Clinical Isolates
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Case Report and Genomic Analysis of Cefiderocol-Resistant Escherichia coli Clinical Isolates
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF CLINICAL PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-06-02
DOI
10.1093/ajcp/aqab115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ResFinder 4.0 for predictions of phenotypes from genotypes
- (2020) Valeria Bortolaia et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cefiderocol Resistance in Acinetobacter baumannii: Roles of β-Lactamases, Siderophore Receptors, and Penicillin Binding Protein 3
- (2020) Saquib Malik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reduced susceptibility mechanism to cefiderocol, a siderophore cephalosporin, among clinical isolates from a global surveillance programme (SIDERO-WT-2014)
- (2020) Naoki Kohira et al. Journal of Global Antimicrobial Resistance
- Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report
- (2019) Enrico Maria Trecarichi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Compassionate use of cefiderocol in the treatment of an intraabdominal infection due to multidrug resistant Pseudomonas aeruginosa : A case report
- (2019) Ryan W. Stevens et al. PHARMACOTHERAPY
- Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin
- (2019) Takafumi Sato et al. CLINICAL INFECTIOUS DISEASES
- Emergence of NDM-5-producing Escherichia coli sequence type 167 clone in Italy
- (2018) Maria Giufrè et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Rapid and precise alignment of raw reads against redundant databases with KMA
- (2018) Philip T. L. C. Clausen et al. BMC BIOINFORMATICS
- Compassionate Use of Cefiderocol as Adjunctive Treatment of Native Aortic Valve Endocarditis Due to Extremely Drug-resistant Pseudomonas aeruginosa
- (2018) Jonathan D Edgeworth et al. CLINICAL INFECTIOUS DISEASES
- In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015
- (2018) James A. Karlowsky et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Stability of cefiderocol against clinically significant broad-spectrum oxacillinases
- (2018) Laurent Poirel et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study)
- (2018) Krystyna M. Kazmierczak et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens
- (2017) J. Dobias et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Widespread Dissemination of Carbapenem-Resistant Escherichia coli Sequence Type 167 Strains HarboringblaNDM-5in Clinical Settings in China
- (2016) Yonglu Huang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases
- (2016) Tsukasa Ito-Horiyama et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroSusceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)
- (2016) Boudewijn L. M. de Jonge et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Detection of an Escherichia coli Sequence Type 167 Strain with Two Tandem Copies of bla NDM-1 in the Chromosome
- (2016) Ping Shen et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Identification of an NDM-5-producing Escherichia coli Sequence Type 167 in a Neonatal Patient in China
- (2016) Yuan-qi Zhu et al. Scientific Reports
- Pharmacodynamic Profiling of a Siderophore-Conjugated Monocarbam in Pseudomonas aeruginosa: Assessing the Risk for Resistance and Attenuated Efficacy
- (2015) Aryun Kim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Potentiation of Antibacterial Activity of the MB-1 Siderophore-Monobactam Conjugate Using an Efflux Pump Inhibitor
- (2015) Andrew P. Tomaras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli
- (2015) Shawn Vasoo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroAntimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains
- (2015) Naoki Kohira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitroantimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria
- (2015) Akinobu Ito et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characterization ofEscherichia coliNDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3
- (2015) Richard A. Alm et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- blaNDM-5Carried by an IncX3 Plasmid in Escherichia coli Sequence Type 167
- (2014) Ping Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Benchmarking of Methods for Genomic Taxonomy
- (2014) M. V. Larsen et al. JOURNAL OF CLINICAL MICROBIOLOGY
- First identification of coexistence of blaNDM-1 and blaCMY-42 among Escherichia coli ST167 clinical isolates
- (2013) Xueqing Zhang et al. BMC MICROBIOLOGY
- Rapid Whole-Genome Sequencing for Detection and Characterization of Microorganisms Directly from Clinical Samples
- (2013) H. Hasman et al. JOURNAL OF CLINICAL MICROBIOLOGY
- First Identification of Novel NDM Carbapenemase, NDM-7, in Escherichia coli in France
- (2013) Gaelle Cuzon et al. PLoS One
- Targeting iron assimilation to develop new antibacterials
- (2012) Timothy L Foley et al. Expert Opinion on Drug Discovery
- Siderophores as drug delivery agents: application of the “Trojan Horse” strategy
- (2009) Ute Möllmann et al. BIOMETALS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now